Literature DB >> 19091870

Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.

Kevin R Mott1, Catherine J Bresee, Sariah J Allen, Lbachir BenMohamed, Steven L Wechsler, Homayon Ghiasi.   

Abstract

A hallmark of infection with herpes simplex virus type 1 (HSV-1) is the establishment of latency in ganglia of the infected individual. During the life of the latently infected individual, the virus can occasionally reactivate, travel back to the eye, and cause recurrent disease. Indeed, a major cause of corneal scarring (CS) is the scarring induced by HSV-1 following reactivation from latency. In this study, we evaluated the relationship between the amount of CS and the level of the HSV-1 latency-associated transcript (LAT) in trigeminal ganglia (TG) of latently infected mice. Our results suggested that the amount of CS was not related to the amount of virus replication following primary ocular HSV-1 infection, since replication in the eyes was similar in mice that did not develop CS, mice that developed CS in just one eye, and mice that developed CS in both eyes. In contrast, mice with no CS had significantly less LAT, and thus presumably less latency, in their TG than mice that had CS in both eyes. Higher CS also correlated with higher levels of mRNAs for PD-1, CD4, CD8, F4/80, interleukin-4, gamma interferon, granzyme A, and granzyme B in both cornea and TG. These results suggest that (i) the immunopathology induced by HSV-1 infection does not correlate with primary virus replication in the eye; (ii) increased CS appears to correlate with increased latency in the TG, although the possible cause-and-effect relationship is not known; and (iii) increased latency in mouse TG correlates with higher levels of PD-1 mRNA, suggesting exhaustion of CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091870      PMCID: PMC2643740          DOI: 10.1128/JVI.02234-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Viral regulation of the long distance axonal transport of herpes simplex virus nucleocapsid.

Authors:  J H LaVail; A N Tauscher; A Sucher; O Harrabi; R Brandimarti
Journal:  Neuroscience       Date:  2007-03-26       Impact factor: 3.590

2.  Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.

Authors:  T M Tumpey; H Cheng; D N Cook; O Smithies; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection.

Authors:  H Ghiasi; S Cai; G C Perng; A B Nesburn; S L Wechsler
Journal:  Antiviral Res       Date:  2000-01       Impact factor: 5.970

Review 4.  Classification of herpes simplex virus keratitis and anterior uveitis.

Authors:  T J Liesegang
Journal:  Cornea       Date:  1999-03       Impact factor: 2.651

5.  Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.

Authors:  H Ghiasi; G Perng; A B Nesburn; S L Wechsler
Journal:  Microb Pathog       Date:  1999-12       Impact factor: 3.738

6.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.

Authors:  Z S Zhao; F Granucci; L Yeh; P A Schaffer; H Cantor
Journal:  Science       Date:  1998-02-27       Impact factor: 47.728

7.  Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10.

Authors:  T M Tumpey; H Cheng; X T Yan; J E Oakes; R N Lausch
Journal:  J Leukoc Biol       Date:  1998-04       Impact factor: 4.962

8.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

Authors:  E John Wherry; Sang-Jun Ha; Susan M Kaech; W Nicholas Haining; Surojit Sarkar; Vandana Kalia; Shruti Subramaniam; Joseph N Blattman; Daniel L Barber; Rafi Ahmed
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

9.  Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia.

Authors:  Todd P Margolis; Fred L Elfman; David Leib; Nazzy Pakpour; Kathleen Apakupakul; Yumi Imai; Cindy Voytek
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  The corneas of naive mice contain both CD4+ and CD8+ T cells.

Authors:  Kevin R Mott; Yanira Osorio; Donald J Brown; Naoyuki Morishige; Andrew Wahlert; James V Jester; Homayon Ghiasi
Journal:  Mol Vis       Date:  2007-09-28       Impact factor: 2.367

View more
  57 in total

1.  Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.

Authors:  Sariah J Allen; Kevin R Mott; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Authors:  David J Davido; Eleain M Tu; Hong Wang; Maria Korom; Andreu Gazquez Casals; P Jahnu Reddy; Heba H Mostafa; Benjamin Combs; Steve D Haenchen; Lynda A Morrison
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.

Authors:  Aziz Alami Chentoufi; Gargi Dasgupta; Anthony B Nesburn; Ilham Bettahi; Nicholas R Binder; Zareen S Choudhury; Winston D Chamberlain; Steven L Wechsler; Lbachir BenMohamed
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

4.  The Absence of DHHC3 Affects Primary and Latent Herpes Simplex Virus 1 Infection.

Authors:  Shaohui Wang; Kevin R Mott; Marianne Cilluffo; Casey L Kilpatrick; Shoko Murakami; Alexander V Ljubimov; Konstantin G Kousoulas; Sita Awasthi; Bernhard Luscher; Homayon Ghiasi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 5.  Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.

Authors:  Arif Azam Khan; Ruchi Srivastava; Patricia Prado Lopes; Christine Wang; Thanh T Pham; Justin Cochrane; Nhi Thi Uyen Thai; Lucas Gutierrez; Lbachir Benmohamed
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

6.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

7.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

8.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  [Acute retinal necrosis from the virologist's perspective].

Authors:  P Rautenberg; L Grancicova; J Hillenkamp; B Nölle; J B Roider; H Fickenscher
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

10.  HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection.

Authors:  Arpeet Shah; Asim V Farooq; Vaibhav Tiwari; Min-Jung Kim; Deepak Shukla
Journal:  Mol Vis       Date:  2010-11-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.